MainboardGMP
LIVE
LIVE GMP
Watrana Rentals Ltd₹0·Crystal Crop Protection Ltd₹+45·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·M.K.Sons Fine Jewels Ltd₹+3·Watrana Rentals Ltd₹0·Crystal Crop Protection Ltd₹+45·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·M.K.Sons Fine Jewels Ltd₹+3·
Home › IPOs › Aristo Bio-Tech & Lifescience Ltd.
AR
Aristo Bio-Tech & Lifescience Ltd.
CLOSED NSE SME Fixed Price IPO Fresh Capital Aristo Bio-Tech & Lifescience IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹72
Issue Price: ₹ 72
Issue Price
₹72
Face Value
₹10
Lot Size
1,600 shares
Open Date
16 Jan 2023
Close Date
19 Jan 2023
Allotment
24 Jan 2023
Listing Date
30 Jan 2023
Exchange
NSE SME
Aristo Bio-Tech & Lifescience IPO About the Company

Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company. They are mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides.

They deliver their products in India as well as engage in exporting products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators, and a wide variety of other Agrochemicals.

The industry Aristo Bio-Tech and Lifescience is engaged in, is full of possibilities where the entities deal in the production and distribution of pesticides and fertilizers. All these entities contribute towards enhancing crop yields and their quality.

Aristo Bio-Tech and Lifescience are delivering their products in over 20 states of India. Also, the offerings are extended to over 15 countries, including Armenia, Australia, Bangladesh, Belgium, Cambodia, Germany, Italy, Kenya, Moldova, New Zealand, Poland, South Africa, UAE, Ukraine, and Vietnam.

The company is ISO 9001: 2015 certified for their Quality Management System. Following are the products of Aristo:

  • Herbicides/Weedicides
  • Fungicides
  • Plant Growth Regulator
  • Insecticides

Alongside undertaking manufacturing operations, the company also provide Contract manufacturing, Job work and Toll manufacturing services for Crop Protection companies.

...read more
Aristo Bio-Tech & Lifescience IPO Objects of the Issue
Purpose Amount (₹ Cr)
To Meet Working Capital Requirement ₹9
General Corporate Expenses ₹3
Public Issue Expenses ₹1
Aristo Bio-Tech & Lifescience IPO Lead Managers
Beeline Capital Advisors Pvt.Ltd
Financial Summary Amount in ₹ Lakhs
Metric 30-Sep-22 31-Mar-22 31-Mar-21
Total Assets 10,869 7,700 8,142
Revenue 12,907 16,603 16,723
PAT 259 146 108
Net Worth 1,743 1,484 1,338
Reserves 1,244 985 839
Total Borrowing 2,936 2,548 2,225
Issue Details
Total Shares Offered
1,812,800 (100%)
Reserved for Market Maker
Up to ₹1 Cr
Net Offer to Public
Up to ₹12 Cr
Pre-Issue Shareholding
4,995,000 shares
Post-Issue Shareholding
6,807,800 shares
UPI Mandate
19 Jan 2023
IPO Analytics Dashboard
LIVE
Aristo Bio-Tech & Lifescience IPO GMP Insights
👤
Retail Demand
Strong
💼
HNI Interest
Strong
📊
Valuation
Strong
Aristo Bio-Tech & Lifescience IPO GMP Strength Score
9 / 10 Strong
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Aristo Bio-Tech & Lifescience IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
💼 NII / HNI — 860,800 (47%) —
👤 Retail (RII) — 860,800 (47%) —
📊 Market Maker — 91,200 (5%) —
Σ Total — 1,812,800 (100%) —

* Amount calculated at upper price band (₹72) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
💼
NII / HNI ? 860,800 (47%)
47%
👤
Retail (RII) ? 860,800 (47%)
47%
📊
Market Maker ? 91,200 (5%)
5%
Total Shares Offered 1,812,800 (100%)
Aristo Bio-Tech & Lifescience IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 1,600
Min. Investment ₹115,200
💼 HNI Investors ?
Min. Lots 2
Min. Shares 3,200
Min. Investment ₹230,400
Aristo Bio-Tech & Lifescience IPO Valuation — EPS & P/E Pre & post-issue metrics
Pre-Issue P/E ?
9 x
Aristo Bio-Tech & Lifescience IPO Timeline & Key Dates
  1. 1 💳 Initiation of Refund 25 Jan 2023
  2. 2 📂 Credit of Shares to Demat 27 Jan 2023
Investor Interpretation
  • Retail allocation is strong at 47% of the total offering.
  • HNI/NII demand is strong at 47%.
  • The IPO P/E of 9x reflects a strong valuation relative to typical market ranges.

This IPO shows strong fundamentals and healthy investor demand. Research the business model and compare with sector peers before applying.

STOCK PRICE HISTORY  ·  NSE
—
Issue Price: ₹ 72  ·  Symbol: —
H —
L —
O —
Aristo Bio-Tech & Lifescience IPO Company Info
📍 E-24,25,26, G.I.D.C. Manjusar, Ta. Savli, Vadodara, Gujarat, 391775
Visit Website
Aristo Bio-Tech & Lifescience IPO Registrar
MUFG Intime India Pvt.Ltd
Check Allotment Status
Aristo Bio-Tech & Lifescience IPO FAQs
Aristo Bio-Tech & Lifescience IPO has already listed. Its last recorded GMP was ₹0. GMP is only indicative and never a guarantee of listing gains.
The issue price of Aristo Bio-Tech & Lifescience IPO is ₹72 per share. One lot has 1,600 shares, so the minimum investment is about ₹115,200. It is a Fresh Capital issue.
Aristo Bio-Tech & Lifescience IPO opened on 16 Jan 2023 and closed on 19 Jan 2023. Allotment is tentatively finalised on 24 Jan 2023. Shares are listed on NSE SME on 30 Jan 2023.
Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company. They are mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides.
As per the offer document, Aristo Bio-Tech & Lifescience plans to use the IPO proceeds for: To Meet Working Capital Requirement (₹9); General Corporate Expenses (₹3); Public Issue Expenses (₹1).
The lead manager of Aristo Bio-Tech & Lifescience IPO is Beeline Capital Advisors Pvt.Ltd.
Aristo Bio-Tech & Lifescience IPO is proposed to list on NSE SME; it is a Fixed Price IPO and the issue is a Fresh Capital.
Disclaimer

The information on mainboardgmp.com is provided for educational and informational purposes only.

We are not a Securities and Exchange Board of India (SEBI)-registered investment advisor, analyst, broker, or financial planner. The content, data, and insights on this website, including Grey Market Premium (GMP), subscription data, IPO dates, and market information, are not intended as financial advice or recommendations to buy, sell, or hold securities.

GMP and related IPO data are collected from unofficial market sources and may not reflect actual IPO listing performance or future price movements. You should not rely solely on the information provided here to make financial or investment decisions.

Investing in IPOs and securities involves risk. Always conduct your own research and consult a qualified SEBI-registered financial advisor before making investment decisions. mainboardgmp.com and its owners shall not be liable for any financial losses, trading losses, or damages arising from use of this website.

By using this website, you acknowledge and agree that you use the content at your own risk.